Navigation Links
Aspartame is safe, study says
Date:9/11/2007

Looking at more than 500 reports, including toxicological, clinical and epidemiological studies dating from 1970s preclinical work to the latest studies on the high-intensity sweetener, along with use levels and regulations data, an international expert panel from 10 universities and medical schools evaluated the safety of aspartame for people of all ages and with a variety of health conditions. Their study is published in the September issue of Critical Reviews in Toxicology.

There have been continued questions in the media and on the internet about the safety of aspartame, said panel member and University of Maryland food and nutrition professor Bernadene Magnuson. Our study is a very comprehensive review of all of the research thats been done on aspartame. Never before has a group with the breadth of experience of this panel looked at this question.

Aspartame

A non-nutritive sweetener, aspartame is approximately 200 times sweeter than sucrose, the accepted standard for sweetness. Though aspartame has the same number of calories as sugar on a weight-to-weight basis, it can be added to food or pharmaceuticals at a fraction of what would be needed with sucrose to achieve the same sweetness, with far fewer calories.

Aspartame was discovered by accident in 1965, and since then has become a popular sweetener in more than 6000 food and pharmaceutical products that range from soft drinks to ketchup.

Aspartame Consumption

The panel used the latest data 2001-02 -- from the National Health and Nutrition Examination Surveys (NHANES) to determine the most current levels of aspartame consumption.

Even the very highest consumers of aspartame are well below the acceptable daily intake (ADI) and well below the amounts used in animal testing, said Magnuson.

Evaluation Findings

The team reviewed studies that tested a number of health effects of varying levels of aspartame, including amounts that far exceed the acceptable daily intake, on animals and humans. In addition to healthy adults and children, studies also looked at effects on adults and children with diabetes, hyperactive and sugar-sensitive children, and people with Parkinsons disease and depression.

The Expert Panels evaluation concluded the following:

Overall:

Aspartame is safe at current levels of consumption, which remain well below established ADI levels, even among high user sub-populations. No credible evidence was found that aspartame is carcinogenic, neurotoxic or has or any other adverse effects when consumed even at levels many times the established ADI levels.

Specifically:

  • Based on results of several long term studies, aspartame does not have carcinogenic or cancer-promoting activity.
  • Results of extensive investigation in studies that mimic human exposure do not show any evidence of neurological effects, such as memory and learning problems, of aspartame consumption.
  • Overall the weight of the evidence indicates that aspartame has no effect on behavior, cognitive function, neural function or seizures in any of the groups studied.
  • Aspartame has not been shown to have adverse effects on reproductive activity or lactation.
  • Studies conclude that aspartame is safe for use by diabetics and may aid diabetics in adhering to a sugar-free diet.
  • There is no evidence to support an association between aspartame consumption and obesity. On the contrary, when used in multidisciplinary weight control programs, aspartame may actually aid in long-term weight control.
  • The studies provide no evidence to support an association between aspartame and brain or hematopoietic tumor development.


'/>"/>

Contact: Ellen Ternes
eternes@umd.edu
301-405-4627
Kellen Communications
Source:Eurekalert

Related medicine news :

1. Aspartame, Artificial Sweetener, A Safe Bet!
2. MP Calls For Ban On Aspartame
3. Artificial sweetener, Aspartame, may be the potential cause of lymphoma, leukaemia
4. Aspartame Probe Call Rejected by FDA
5. Shorter Post-Operative Recovery Stay After Tonsillectomy for Kids Safe, Cost-Efficient
6. Rural Canadians travel far for specialists: study
7. A new study surpasses Gene Therapy Hurdle
8. Tomato Sauce reduces Cancer Risk- Study
9. A question on study of Adult Stem Cell
10. Study on obesity and heart failure
11. National Lung Study in the process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
(Date:3/27/2017)... Orange, Texas (PRWEB) , ... March 27, 2017 ... ... celebration at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to ... giveaways and will be an opportunity for area-residents to celebrate two great years ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin ... a prestigious award honoring the top influencers on RealSelf—the most trusted online destination ... doctors and clinics. , In 2016, more than 82 million people visited RealSelf ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter ... the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to ... premier prehospital trauma education developed in cooperation with the American College of Surgeons ...
(Date:3/24/2017)... ... ... The Radiology Business Management Association (RBMA) has named the nine winners ... year, are among the most prestigious in radiology marketing because a panel of radiology ... recognize achievements in both large budget (over $5,000) and small budget (under $5,000) campaigns. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
Breaking Medicine Technology: